drugset / Trial / NCT06836791

Topical 15% Trichloroacetic Acid Versus Silver Nitrate Cauterization in the Management of Idiopathic Childhood Epistaxis: A Prospective Double-Blinded, Randomized Clinical Trial

NCT06836791

RandomizedParallel-groupDouble-blindTreatment

Summary

the invistigators aim to explore the efficacy of trichloroacetic acid as a chemical cauterization agent and compare it with that of silver nitrate in the treatment of idiopathic epistaxis in children.

Timeline

Start
2023-03-01
Primary completion
2024-10-01
Completion
2024-11-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Silver Nitrate Other / unclassified 25 % Topical
Subject Trichloroacetic acid Small molecule 15 % Topical

Indications

No indication recorded.